Ju-Hee Bang
Impact in
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- HER2/EGFR in Cancer Research
- Inflammatory Biomarkers in Disease Prognosis
- PARP inhibition in cancer therapy
-
- Chronic Lymphocytic Leukemia Research
Papers in
- Co-authors
- Do‐Youn Oh (15 shared papers)Ah-Rong Nam (15 shared papers)Yung‐Jue Bang (12 shared papers)Ji Eun Park (7 shared papers)Mei Hua Jin (6 shared papers)Kyung-Hun Lee (4 shared papers)Mei Jin (2 shared papers)Sae‐Won Han (3 shared papers)
- Journals
- Cancer Research and Treatment (6 papers)Gastric Cancer (4 papers)Molecular Cancer Therapeutics (2 papers)Cancer Letters (2 papers)Scientific Reports (1 paper)
- Partner nations
- South KoreaUnited StatesPuerto Rico
In The Last Decade
Ju-Hee Bang
17 papers receiving 377 citations
Peers
Comparison fields: 5 of 46
- Oncology 247
- Genetics 53
- Hematology 51
- Pulmonary and Respiratory Medicine 105
- Immunology 64
Countries citing papers authored by Ju-Hee Bang
This map shows the geographic impact of Ju-Hee Bang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ju-Hee Bang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ju-Hee Bang more than expected).
Fields of papers citing papers by Ju-Hee Bang
This network shows the impact of papers produced by Ju-Hee Bang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ju-Hee Bang. The network helps show where Ju-Hee Bang may publish in the future.
Co-authors
The 25 scholars most cited alongside Ju-Hee Bang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 51 | |
| 2 | 2017 | 47 | |
| 3 | 2012 | 38 | |
| 4 | 2019 | 30 | |
| 5 | 2018 | 26 | |
| 6 | 2021 | 25 | |
| 7 | 2019 | 25 | |
| 8 | 2019 | 24 | |
| 9 | 2021 | 18 | |
| 10 | 2015 | 16 | |
| 11 | 2014 | 16 | |
| 12 | 2018 | 14 | |
| 13 | 2019 | 13 | |
| 14 | 2020 | 12 | |
| 15 | 2017 | 11 | |
| 16 | 2016 | 9 | |
| 17 | 2018 | 5 |
About Ju-Hee Bang
Ju-Hee Bang is a scholar working on Oncology, Surgery, Molecular Biology, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine, having authored 17 papers that have together received 380 indexed citations. Recurring topics across this work include Cholangiocarcinoma and Gallbladder Cancer Studies (7 papers), Cancer Immunotherapy and Biomarkers (4 papers), Chronic Myeloid Leukemia Treatments (3 papers), Pancreatic and Hepatic Oncology Research (3 papers), Cancer Mechanisms and Therapy (3 papers), Drug Transport and Resistance Mechanisms (3 papers), Peptidase Inhibition and Analysis (2 papers) and Eosinophilic Disorders and Syndromes (2 papers). The work is most often cited by research in Oncology (247 citations), Genetics (53 citations), Hematology (51 citations), Pulmonary and Respiratory Medicine (105 citations) and Immunology (64 citations). Ju-Hee Bang has collaborated with scholars based in South Korea, United States and Puerto Rico. Frequent co-authors include Do‐Youn Oh, Ah-Rong Nam, Yung‐Jue Bang, Ji Eun Park, Mei Hua Jin, Kyung-Hun Lee, Mei Jin, Sae‐Won Han, Tae‐Yong Kim and Seock‐Ah Im. Their work appears in journals such as Cancer Research and Treatment, Gastric Cancer, Molecular Cancer Therapeutics, Cancer Letters and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.